Rewalk Robotics Ltd (RWLK) reported quarterly earnings results on Thursday, Aug-4-2016. The company reported $-0.64 earnings per share for the quarter, missing the analyst consensus estimate by $-0.13. Analysts had a consensus of $-0.51. The company posted revenue of $.82 million in the period, compared to analysts expectations of $2.10 million. The company’s revenue was up 34.4% compared to the same quarter last year.
Many Wall Street Analysts have commented on Rewalk Robotics Ltd. Piper Jaffray Initiated Rewalk Robotics Ltd on Jul 15, 2016 to “Overweight”, Price Target of the shares are set at $10.
Rewalk Robotics Ltd closed down -0.24 points or -3.56% at $6.5 with 45,414 shares getting traded on Tusday. Post opening the session at $6.8, the shares hit an intraday low of $6.4 and an intraday high of $6.87 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
In a different news, on May 26, 2016, Jodi Gricci (VP Global Marktng & Training) sold 329 shares at $10.66 per share price. According to the SEC, on May 26, 2016, John Vincent Hamilton (VP, Regulatory & Clinical) sold 329 shares at $10.66 per share price.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing to commercialize ReWalk an exoskeleton that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk is a product that can fundamentally change the health and life experiences of users. ReWalk controls movement using subtle changes in the users center of gravity.